ID

26224

Descrição

Study ID: 101468/125 Clinical Study ID: SKF-101468/125 Study Title: A double-blind, multicentre, flexible dose, L-dopa controlled study of ropinirole to investigate A) neuroprotective effect as measured by 3D PET scanning, and B) ophthalmological safety, in patients with early Parkinson’s disease Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: requip Study Indication: Restless Legs Syndrome

Palavras-chave

Versões (1)
  1. 12/10/2017 12/10/2017 -
Titular dos direitos

GlaxoSmithKline

Transferido a

12 de outubro de 2017

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 3.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

L-dopa controlled study of ropinirole, neuroprotective effect and ophthalmological safety in early Parkinson’s disease 101468/125 Module 1 Concomitant Medication/Adverse Experiences

Inglês

L-dopa controlled study of ropinirole, neuroprotective effect and ophthalmological safety in early Parkinson’s disease 101468/125 Module 1 Concomitant Medication/Adverse Experiences

1 Formulários  
Concomitant Medication Information
Descrição

Concomitant Medication Information

Concomitant Medication Information noticed
Descrição

Concomitant Medication Information

Tipo de dados

boolean

Concomitant Medication
Descrição

Concomitant Medication

Drug Name (Trade Name Preferred)
Descrição

Drug Name (Trade Name Preferred)

Tipo de dados

text

Total daily dose (e.g. 500 mg)
Descrição

Total daily dose

Tipo de dados

integer

Unidades de medida
  • mg
mg
Medical Condition
Descrição

Medical Condition

Tipo de dados

text

Approximate Start Date
Descrição

Approximate Start Date

Tipo de dados

date

End Date (leave blank if continuing)
Descrição

End Date

Tipo de dados

date

Continuing
Descrição

Continuing

Tipo de dados

boolean

For SB
Descrição

For SB

Tipo de dados

text

Adverse Experiences
Descrição

Adverse Experiences

Definition of serious adverse experiences
Descrição

A serious adverse experience is any experience which is -fatal -life threatening - disabling - incapacitating - results in hospitalization - prolongs a hospital stay - associated with congenital abnormality, carcinoma or overdose

Tipo de dados

boolean

Adverse Experience Details
Descrição

Adverse Experience Details

Experience
Descrição

Experience

Tipo de dados

text

For SB
Descrição

For SB

Tipo de dados

text

Date Started
Descrição

Date Started

Tipo de dados

date

Date Stopped
Descrição

Date Stopped

Tipo de dados

date

Duration (if less than 24hrs)
Descrição

Duration

Tipo de dados

float

Unidades de medida
  • hrs
hrs
Experience continuing
Descrição

Experience continuing

Tipo de dados

boolean

Course: Continuous
Descrição

Course

Tipo de dados

boolean

If No, no. of episodes
Descrição

No. of episodes

Tipo de dados

integer

Intensity
Descrição

Intensity

Tipo de dados

text

Action taken on Study Medication
Descrição

Action taken on Study Medication

Tipo de dados

integer

Suspected Relationship
Descrição

Suspected Relationship

Tipo de dados

text

Corrective Therapy
Descrição

Corrective Therapy

Tipo de dados

text

Do you consider this a serious adverse experience by the definitions on the tab?
Descrição

If patient died complete Form D

Tipo de dados

integer

Investigator´s Signature
Descrição

Investigator´s Signature

Investigator´s Signature
Descrição

Investigator´s Signature

Tipo de dados

text

Date
Descrição

Date

Tipo de dados

date

Voltar ao início da página

Similar models

L-dopa controlled study of ropinirole, neuroprotective effect and ophthalmological safety in early Parkinson’s disease 101468/125 Module 1 Concomitant Medication/Adverse Experiences

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Concomitant Medication Information
Concomitant Medication Information
Item
Concomitant Medication Information noticed
boolean
Item Group
Concomitant Medication
Drug Name (Trade Name Preferred)
Item
Drug Name (Trade Name Preferred)
text
Total daily dose
Item
Total daily dose (e.g. 500 mg)
integer
Medical Condition
Item
Medical Condition
text
Approximate Start Date
Item
Approximate Start Date
date
End Date
Item
End Date (leave blank if continuing)
date
Continuing
Item
Continuing
boolean
For SB
Item
For SB
text
Item Group
Adverse Experiences
Definition of serious adverse experiences
Item
Definition of serious adverse experiences
boolean
Item Group
Adverse Experience Details
Experience
Item
Experience
text
For SB
Item
For SB
text
Date Started
Item
Date Started
date
Date Stopped
Item
Date Stopped
date
Duration
Item
Duration (if less than 24hrs)
float
Experience continuing
Item
Experience continuing
boolean
Course
Item
Course: Continuous
boolean
No. of episodes
Item
If No, no. of episodes
integer
Item
Intensity
text
Intensity
Code List
Intensity
CL Item
Mild (1)
CL Item
Moderate (2)
CL Item
Severe (3)
Item
Action taken on Study Medication
integer
Action taken on Study Medication
Code List
Action taken on Study Medication
CL Item
None (1)
CL Item
Dose decreased  (2)
CL Item
Dose increased (3)
CL Item
Drug stopped (4)
CL Item
Dose interrupted (5)
Item
Suspected Relationship
text
Suspected Relationship
Code List
Suspected Relationship
CL Item
Related (1)
CL Item
Possibly related (2)
CL Item
Probably unrelated  (3)
CL Item
Unrelated (4)
Item
Corrective Therapy
text
Corrective Therapy
Code List
Corrective Therapy
CL Item
Yes (If "Yes" record on Medication form) (1)
CL Item
No (2)
Item
Do you consider this a serious adverse experience by the definitions on the tab?
integer
Serious Adverse Experience by Definition
Code List
Do you consider this a serious adverse experience by the definitions on the tab?
CL Item
Yes (If "Yes", report to SB by telephone within 24 hours) (1)
CL Item
No (2)
Item Group
Investigator´s Signature
Investigator´s Signature
Item
Investigator´s Signature
text
Date
Item
Date
date
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial